# An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

> **NCT05685732** · PHASE4 · COMPLETED · sponsor: **Corium, Inc.** · enrollment: 246 (actual)

## Conditions studied

- Attention Deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05685732
- **Lead sponsor:** Corium, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2024-05-02
- **Final completion:** 2024-05-02
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05685732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05685732, "An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05685732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*